1. Home
  2. GEMI vs IOVA Comparison

GEMI vs IOVA Comparison

Compare GEMI & IOVA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Gemini Space Station Inc.

GEMI

Gemini Space Station Inc.

N/A

Current Price

$4.09

Market Cap

1.2B

Sector

N/A

ML Signal

N/A

Logo Iovance Biotherapeutics Inc.

IOVA

Iovance Biotherapeutics Inc.

HOLD

Current Price

$3.55

Market Cap

1.4B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
GEMI
IOVA
Founded
2014
2007
Country
United States
United States
Employees
N/A
975
Industry
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.2B
1.4B
IPO Year
N/A
2008

Fundamental Metrics

Financial Performance
Metric
GEMI
IOVA
Price
$4.09
$3.55
Analyst Decision
Buy
Buy
Analyst Count
9
10
Target Price
$10.44
$9.11
AVG Volume (30 Days)
1.9M
15.9M
Earning Date
03-19-2026
05-07-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
14.84
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
$69.77
$51.55
Revenue Next Year
$47.76
$37.55
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$4.55
$1.64
52 Week High
$34.67
$5.63

Technical Indicators

Market Signals
Indicator
GEMI
IOVA
Relative Strength Index (RSI) 26.33 45.36
Support Level N/A $2.02
Resistance Level $9.94 $4.34
Average True Range (ATR) 0.66 0.33
MACD -0.31 -0.13
Stochastic Oscillator 0.68 5.87

Price Performance

Historical Comparison
GEMI
IOVA

About GEMI Gemini Space Station Inc.

Gemini Space Station Inc is engaged on unlocking the next era of financial, creative, and personal freedom. It envisions a future where crypto will redesign the global financial system, the internet, and money in a way that provides greater choice, independence, and opportunity for all. As a trusted bridge between the traditional financial system and the emerging crypto economy, It is providing access for individuals and institutions to a decentralized future that is more open, fair, and secure. Its core exchange product has expanded over time to become a comprehensive platform for its users to engage with the crypto economy, including a derivatives exchange, staking services, an over-the-counter (OTC) trading desk, institutional-grade custody, and others.

About IOVA Iovance Biotherapeutics Inc.

Iovance Biotherapeutics Inc is a clinical-stage biopharmaceutical company, pioneering a transformational approach to treating cancer by harnessing the human immune system's ability to recognize and destroy diverse cancer cells using therapies personalized for each patient. The company is preparing for potential U.S. regulatory approvals and commercialization of the first autologous T-cell therapy to address a solid tumor cancer. It operates in one segment, focusing on innovating, developing, and commercializing therapies using its autologous TIL cell therapies for patients with solid tumor cancers. Geographically, the company operates in United States and Rest of the World.

Share on Social Networks: